Robert L. Nussbaum, Chief Medical Officer at Invitae Corp (NVTA), sold 39,176 shares at $6.69 ($262K) on 2022-03-14, disclosed to the SEC on 2022-03-16.
Seasonal sale ($262k) by Chief Medical Officer — this insider has traded NVTA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.69 | 19,588 | $131K | 50.0% |
| 2 | $6.69 | 19,588 | $131K | 50.0% |
| Total | $6.69 avg | 39,176 | $262K | 100% |
| Filing → |
| NVTA | SELL | 2023-03-15 | $4K | — | Filing → |
| NVTA | SELL | 2022-08-18 | $32K | — | Filing → |
| NVTA | SELL | 2022-05-19 | $23K | — | Filing → |